Fluconazole induced multifocal bullous eruptions: a case report

Authors

  • Subhankar Choudhury Department of Pharmacology and Therapeutics, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
  • Bhulan Prasad Loc Department of Pharmacology and Therapeutics, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
  • Rati Ranjan Debbarma Department of Pharmacology and Therapeutics, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
  • Arijit Das Department of Pharmacology and Therapeutics, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20162492

Keywords:

Fluconazole, Bullous eruption, Candidiasis, Naranjo causality score

Abstract

The term bullous drug eruption refers to adverse drug reactions that result in fluid filled blisters. Blistering can be due to various medications. A 22 year old primigravida developed bullous lesions on upper limbs, lower legs and face after taking six doses of lumether forte (artemether 80 mg + lumefantrine 480 mg themis medicare ltd) and difenac plus (diclofenac 50 mg + paracetamol 500 mg intermed), and single dose of flucan (fluconazole 150 mg Bombay tablet Mfg co) and mebex (mebendazole 100 mg Cipla Limited). She had a previous history of localized bullous eruption 2 years back after taking a single dose of forcan (fluconazole 150 mg Cipla Limited) for vaginal candidiasis. There are reported cases of bullous eruptions due to diclofenac, mebendazole and paracetamol. However in our case past history of localized bullous eruptions after taking fluconazole, made it superior to other offenders to be suspected as the “probable” culprit. Naranjo causality score was (…+5…).

References

Mahendra A, Gupta S, Sood S, Kumar P. Oral fixed drug eruption due to fluconazole. Indian J Dermatol Venereol Leprol. 2006;72:391.

Gussenhoven MJ, Haak A, Peereboom-Wynia JD, van’t Wout JW. Stevens-Johnson syndrome after fluconazole. Lancet. 1991;338(8759):120.

Ofoma UR, Chapnic EK. Fluconazole induced toxic epidermal necrolysis: a case report. Cases J. 2009;2:9071.

Nath AK, Adityan B, Thappa DM. Multifocal bullous fixed drug eruption due to fluconazole. Indian J Dermatol. 2008;53(3):156-7.

Rzany B, Mockenhaupt M, Baur S, Schröder W, Stocker U, Mueller J, et al. Epidemiology of erythema: exsudativum multiformr majus, Stevens Johnson syndrome and toxic epidermal necrolysis in Germany (1990-92). Structure and results of a population based registry. J Clin Epidemiol. 1996;49:769-73.

Jenkins RE, Hern S, Black MM. Clinical features and management of 87 patients with pemphigoid gestationis. Clin Exp Dermatol. 1999;24(4):255-9.

Garin SB, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxicepidermal necrolysis, Stevens Johnsonsyndrome, and erythema multiforme. Arch Dermatol. 1993;129:92-6.

Justiniano H, Berlingeri-Ramos AC, Sánchez JL. Pattern analysis of drug-induced skin diseases. Am J Dermatopathol. 2008;30(4):352-9.

Ackerman AB, Chongchitnant N, Sanchez J. Histologic diagnosis of inflammatory skin diseases. 2nd ed. Baltimore: Williams and Wilkins; 1997:317.

Konnikov N, Raynham H. Oral antifungal agents. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. Fitzpatrick's Dermatology in General Medicine. 6th ed. New York: McGrawHill; 2003:2443-8.

Downloads

Published

2017-01-05

How to Cite

Choudhury, S., Loc, B. P., Debbarma, R. R., & Das, A. (2017). Fluconazole induced multifocal bullous eruptions: a case report. International Journal of Basic & Clinical Pharmacology, 5(4), 1681–1683. https://doi.org/10.18203/2319-2003.ijbcp20162492

Issue

Section

Case Reports